Racemic 0.25% bupivacaine and 50% enantiomeric excess (S75-R25) 0.25% bupivacaine associated to fentanyl for labor analgesia with patient’s ambulation. Comparative study
Estudo comparativo entre bupivacaína racêmica a 0,25% e bupivacaína com excesso enantiomérico de 50% (S75-R25) a 0,25%, associadas ao fentanil para analgesia de parto com deambulação da parturiente
Carlos Alberto Figueiredo Côrtes ; Luis Fernando Lima Castro ; Maurício Marsaioli Serafim ; Amaury Sanchez Oliveira ; Marcelo Gelmini ; Rodrigo Betiol Petri
Abstract
BACKGROUND AND OBJECTIVES: Clinical studies with levogyrous enantiomers of local anesthetics have shown better safety due to lower cardiotoxicity. Parturients ambulation during labor may be able to shorten it. This study aimed at comparing anesthetic quality and maternal and fetal repercussions, as well as patients’ ambulation and spontaneous micturition ability with continuous epidural racemic or 50% enantiomeric excess (S75-R25) 0.25% bupivacaine, associated to fentanyl during labor.
METHODS: Participated in this study 40 parturients, physical status ASA I and II, single fetus and in labor, submitted to continuous epidural analgesia, who were divided in two groups: Group I received 8 mL (20 mg) of 0.25% bupivacaine (S75-R25) and epinephrine, associated to 100 mg fentanyl; and Group II received racemic 0.25% bupivacaine and epinephrine associated to 100 mg fentanyl. The following parameters were evaluated: onset time, sensory block level, motor block level, Romberg’s test, ambulation and spontaneous micturition ability, labor and delivery time, maternal hemodynamic and respiratory changes in addition to neonates vitality.
RESULTS: There were no statistically significant differences between groups in all evaluated parameters. All parturients presented with muscle strength and ambulation ability and when this was not observed, the reason was Cesarean delivery indication (1 in Group II) or delivery before the time needed to observe such parameter (4 in Group I and 5 in Group II).
CONCLUSIONS0: Both racemic and S75-R25 0.25% bupivacaine associated to fentanyl were effective for labor analgesia.
Keywords
Resumo
JUSTIFICATIVA E OBJETIVOS: Estudos clínicos com enantiômeros levógiros dos anestésicos locais demonstraram maior segurança em função de menor cardiotoxicidade. A deambulação da parturiente durante o trabalho de parto pode abreviar o trabalho de parto. Este estudo visou comparar a qualidade da anestesia e as repercussões maternas e fetais bem como a capacidade de deambulação e micção espontânea das parturientes com o emprego da bupivacaína a 0,25% e da bupivacaína com excesso enantiomérico de 50% (S75-R25) a 0,25%, associadas ao fentanil por via peridural contínua, no trabalho de parto.
MÉTODO: Foram avaliadas 40 parturientes, estado físico ASA I e II, feto único, em trabalho de parto, submetidas a analgesia peridural contínua e divididas em dois grupos: no grupo I, receberam 8 mL (20 mg) de bupivacaína (S75-R25) a 0,25% com epinefrina, associados a 100 µg de fentanil. No grupo II, receberam 8 mL (20 mg) de bupivacaína racêmica a 0,25% com epinefrina, associados a 100 µg de fentanil. Foram avaliados os seguintes parâmetros: tempo de latência, nível de bloqueio sensitivo, grau de bloqueio motor, teste de Romberg, capacidade de deambulação e micção espontânea, duração do trabalho de parto e do período expulsivo, alterações hemodinâmicas e respiratórias maternas além da vitalidade dos recém-nascidos.
RESULTADOS: Não houve diferença estatística significativa entre os grupos nos parâmetros avaliados. Todas as parturientes apresentaram força muscular com capacidade de deambulação, salvo no caso de indicação de cesariana (um caso do grupo II) ou quando o parto aconteceu antes do tempo previsto para avaliação deste parâmetro (quatro casos do grupo I e cinco casos do grupo II).
CONCLUSÕES: Tanto a bupivacaína racêmica quanto a bupivacaína (S75-R25) a 0,25% associadas ao fentanil mostraram ser boa opção para analgesia de parto.
Palavras-chave
Referências
01. Obstetrics & Gynecology - ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician Gynecologists, nº 36, July 2002. Vol 100, nº1, July 2002. [ Links ]
02. Breen TW, McNeil T, Dierenfield L - Obstetric Anesthesia practice in Canadá. Can J Anesth, 2000;47:1230-1242. [ Links ]
03. Nageotte MP, Larson D, Rumney PJ et al - Epidural analgesia compared with combined spinal-epidural analgesia during labor in nulliparous women. N Engl J Med, 1997;337:1715-1719. [ Links ]
04. Simonetti MPB - Ropivacaína: estado atual e perspectivas futuras. Rev Bras Anestesiol, 1995;45:131-145. [ Links ]
05. Robinson JO, Rosen M, Evans JM et al - Maternal opinion about analgesia for labor. A controlled trial between epidural block and intramuscular pethidine combined with inhalation. Anaesthesia, 1980;35:1173-1181. [ Links ]
06. Thorp JA, Hu DH, Albin RM et al - The effect of intrapartum epidural analgesia on nulliparous labor: a randomized, controlled, prospective trial. Am J Obstet Gynecol, 1993;169:851-858. [ Links ]
07. Scott DB, Lee A, Fagan D et al - Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg, 1989;69:563-569. [ Links ]
08. Simonetti MPB, Batista RA, Ferreira FMC - Esteroisomeria, a interface da tecnologia industrial de medicamentos e da racionalização terapêutica. Rev Bras Anestesiol, 1998;48: 390-399. [ Links ]
09. Vale NB, Delfino J - A cosmologia e a esteroseletividade na anestesia regional. Novo desafio à indústria farmacêutica. Rev Bras Anestesiol, 2000;50:254-262. [ Links ]
10. Vallejo MC, Firestone LL - Effect of epidural analgesia with ambulation on labor duration. Anesthesiology, 2001;95:857-861. [ Links ]
11. Wilson MJ, Cooper G, MacArthur C et al - Randomized controlled trial comparing traditional with two “mobile” epidural techniques: anesthetic and analgesic efficacy. Anesthesiology, 2002;97:1567-1575. [ Links ]
12. Albright GA - Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology, 1979;51:285-287. [ Links ]
13. Steinberg RB, Powell G, Hu XH et al - Epidural sufentanil for analgesia for labor and delivery. Reg Anesth, 1989;14:225-228. [ Links ]
14. Polley LS, Columb MO, Wagner DS et al - Dose-dependent reduction of the minimum local analgesia concentration of bupivacaine by sufentanil for epidural analgesia in labor. Anesthesiology, 1998;89:626-632. [ Links ]
15. Pratt SD, Sarna MC, Soni AK et al - The effective concentration (Ec50) of ropivacaine with fentanil for labor epidural analgesia. Anesthesiology, 1997;87:3-910. [ Links ]
16. Chestnut DH, Vincent RD Jr, McGrath JM et al - Does early administration of epidural analgesia affect obstetric outcome in nulliparous women who are receiving intravenous oxytocin? Anesthesiology, 1994;80:1193-1200. [ Links ]
17. Norris MC, Fogel ST, Conway-Long C - Combined spinal-epidural versus epidural labor analgesia. Anesthesiology, 2001;95:913-920. [ Links ]
18. Holt RO, Diehl SJ, Wright JW - Station and cervical dilation at epidural placement in predicting cesarean risk. Obstet Gynecol, 1999;93:281-284. [ Links ]
19. Chestnut DH - Does epidural analgesia during labor affect the incidence of cesarean delivery? Reg Anesth, 1997;22:495-499. [ Links ]
20. Castro LFC, Cavalcanti FS, Oliveira AS et al - Analgesia peridural contínua com fentanil no trabalho de parto. Rev Bras Anestesiol, 1992;42 (Suppl15):45. [ Links ]
21. Gomes MEW, Balle VR, Machado SB et al - Estudo comparativo entre concentrações de bupivacaína a 0,125% e a 0,25% associada ao fentanil para analgesia de parto por via peridural. Rev Bras Anestesiol, 2004;54:467-472. [ Links ]
22. Cohen SE, Yeh JY, Riley ET et al - Walking with labor epidural analgesia: the impact of bupivacaine concentration and a lidocaine-epinephrine test doses. Anesthesiology, 2000;92:387-392. [ Links ]
23. Foster RH, Markham A - Levobupivacaine: a review of its pharmacology and use as local anaesthetic. Drugs, 2000;59: 551-579. [ Links ]
24. Delfino J, Vale NB - Bupivacaína levógira a 0,5% pura versus mistura enantiomérica de bupivacaína (S75-R25) a 0,5% em anestesia peridural para cirurgia de varizes. Rev Bras Anestesiol, 2001;51:474-482.